Novavax Inc (NVAX)

R&D Expenses

$338.42M

TTM · Period ending: · USD

NVAX logo

NVAX R&D Expenses

Latest reported$338.42M
NVAX R&D Expenses ($3.70M → $338.42M)
High-resolution chart · PNG

NVAX r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
336,820,000
391,169,000
737,502,000
1,235,278,000
2,534,508,000
747,027,000
113,842,000
173,797,000
168,435,000
237,939,000
162,644,000
79,435,000
50,308,000
26,061,000
17,885,000
28,032,000
25,780,000
24,334,000
17,600,000
11,529,000
5,075,000
7,369,000
10,058,000
11,501,000
10,775,000
9,358,000
3,400,000
3,400,000
2,900,000
3,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.